Business
Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering
SINGAPORE, May 05, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (“CUPR” or “the Company”), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds as well as cosmeceuticals for the health and beauty sector, today announced the pricing of its firm commitment initial public offering of an aggregate 3,000,000 shares of its Class A Ordinary Shares (“the Offering”), all of which are being offered by CUPR
About this update from Cuprina Holdings (cayman) Limited
[{"type":"image","alt":"Cuprina Holdings (Cayman) LTD","displaySize":"","headline":null,"caption":"Cuprina Holdings (Cayman) LTD","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":73,"url":"https://media.zenfs.com/en/globenewswire.com/402f43f30f35f5ccdd587985aebd2fe7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Vs5DV_xDy69c4LSgVE319A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwMjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/402f43f30f35f5ccdd587985aebd2fe7","width":300,"height":73}},"lazy":false},{"type":"text","content":"SINGAPORE, May 05, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (“CUPR” or “the Company”), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds as well as cosmeceuticals for the health and beauty sector, today announced the pricing of its firm commitment initial public offering of an aggregate 3,000,000 shares of its Class A Ordinary Shares (“the Offering”), all of which are being offered by CUPR at a public offering price of $4.00 per share (“the Offering Price”).","length":569,"tagName":"p"},{"type":"text","content":"The Company has granted the underwriter a 45-day option to purchase up to an additional 450,000 shares of its Class A Ordinary Shares at the Offering Price, representing 15% of the Class A Ordinary Shares sold in the Offering (“the Over-allotment”).","length":249,"tagName":"p"},{"type":"text","content":"Assuming that the Over-allotment is exercised, the Company is expected to receive gross proceeds amounting to $13.80 million, before deducting underwriting discounts and commissions and estimated offering expenses.","length":214,"tagName":"p"},{"type":"text","content":"The shares are expected to begin trading on the NASDAQ Stock Market LLC under the ticker symbol “CUPR” on April 10, 2025. The Offering is expected to close on April 11, 2025, subject to the satisfaction of customary closing conditions.","length":235,"tagName":"p"},{"type":"text","content":"R. F. Lafferty & Co., Inc. (“R. F. Lafferty”), acted as the sole book-running manager for the Offering. Loeb & Loeb LLP, Lee & Lee, Harney Westwood & Riegels Singapore LLP are acting as U.S., Singapore and Cayman Islands legal counsels to the Company, respectively, and Winston & Strawn LLP is acting as U.S. le...